SciVision Biotech Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 111.231 million compared to TWD 109.814 million a year ago. Operating income was TWD 33.236 million compared to TWD 40.479 million a year ago. Net income was TWD 24.640 million compared to TWD 36.320 million a year ago. Basic earnings per share from continuing operations was TWD 0.4 compared to TWD 0.6 a year ago. Diluted earnings per share from continuing operations was TWD 0.4 compared to TWD 0.58 a year ago.